What is the recommended dilution fluid and ratio for Aztreonam (Aztreonam) intravenous (IV) solution?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Aztreonam IV Dilution and Administration

Aztreonam should be diluted in Sterile Water for Injection, 0.9% Sodium Chloride, or other compatible IV solutions at concentrations not exceeding 2% w/v (20 mg/mL), and administered either as a bolus over 3-5 minutes or as an infusion over 20-60 minutes. 1

Recommended Dilution Fluids

Aztreonam is compatible with multiple IV solutions for dilution 1:

Primary Options:

  • Sterile Water for Injection, USP 1
  • 0.9% Sodium Chloride Injection, USP 1
  • 5% or 10% Dextrose Injection, USP 1
  • Lactated Ringer's Injection, USP 1

Additional Compatible Solutions:

  • Dextrose and Sodium Chloride combinations (5%:0.9%, 5%:0.45%, 5%:0.2%) 1
  • Sodium Lactate Injection (M/6 Sodium Lactate) 1
  • Various balanced salt solutions (Normosol-R, Isolyte E, Plasma-Lyte M) 1
  • 5% or 10% Mannitol Injection 1

Dilution Ratios and Preparation

For IV Bolus Injection:

  • Reconstitute vial with 6-10 mL Sterile Water for Injection 1
  • This creates a concentrated solution for direct slow injection 1

For IV Infusion:

  • Initial reconstitution: Add at least 3 mL Sterile Water for Injection per gram of aztreonam 1
  • Further dilution: Transfer to compatible IV solution to achieve final concentration not exceeding 2% w/v (20 mg/mL) 1
  • For a standard 2g dose, this means a minimum final volume of 100 mL 1

Administration Methods

Bolus Administration:

  • Inject slowly over 3-5 minutes directly into vein or IV tubing 1
  • Flush tubing before and after if administering with incompatible drugs 1

Infusion Administration:

  • Complete infusion within 20-60 minutes 1
  • Standard adult dosing is 2g IV every 8 hours for serious gram-negative infections including hospital-acquired pneumonia 2

Stability Considerations

Storage at Room Temperature (15-30°C):

  • Solutions ≤2% w/v: Use within 48 hours 1
  • Solutions >2% w/v in Sterile Water or 0.9% NaCl: Use within 48 hours 1
  • Solutions >2% w/v in other diluents: Use promptly 1

Refrigerated Storage (2-8°C):

  • Solutions ≤2% w/v: Use within 7 days 1
  • Solutions >2% w/v in Sterile Water or 0.9% NaCl: Use within 7 days 1

Critical Incompatibilities

Aztreonam is incompatible with the following and must not be mixed 1:

  • Nafcillin sodium 1
  • Cephradine 1
  • Metronidazole 1

When using Y-site administration with other drugs, flush the common delivery tube before and after aztreonam delivery 1. The stability of aztreonam decreases when mixed with ampicillin, though ampicillin stability paradoxically increases 3.

Pharmacokinetic Rationale

The recommended dilution and administration approach is based on aztreonam's pharmacokinetic profile 4, 5:

  • Peak serum levels occur within 5 minutes after IV bolus 4
  • Elimination half-life is 1.7 hours 4, 5
  • After a 2g IV dose, therapeutic concentrations exceed MIC90 for most Enterobacteriaceae for 8 hours and for Pseudomonas aeruginosa for 6 hours 4
  • Volume of distribution is approximately 0.16-0.18 L/kg 4, 5

Common Pitfalls to Avoid

  • Do not use glucose-containing solutions if preparing high-concentration (>2% w/v) solutions for extended storage, as stability data are limited 1
  • Do not mix with incompatible antibiotics in the same container or Y-site without adequate flushing 1
  • Do not exceed 2% w/v concentration for routine infusions to ensure stability 1
  • Adjust dosing in renal impairment, as 60-70% is excreted unchanged in urine 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Stability of intravenous admixtures of aztreonam and ampicillin.

American journal of hospital pharmacy, 1985

Research

How and why aztreonam works.

Surgery, gynecology & obstetrics, 1990

Research

Clinical pharmacokinetics of aztreonam.

Clinical pharmacokinetics, 1988

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.